Key result
Right stellate ganglion block plus dexmedetomidine cuts arrhythmia duration ~69% versus control in rats.
Why the study?
To evaluate right stellate ganglion block plus dexmedetomidine in a rat model of atrial fibrillation-like atrial tachyarrhythmia.
Does right stellate ganglion block combined with dexmedetomidine reduce arrhythmia duration and structural remodeling in a rat model of AF-like atrial tachyarrhythmia?
Does right stellate ganglion block combined with dexmedetomidine reduce arrhythmia duration and structural remodeling in a rat model of AF-like atrial tachyarrhythmia?
Absolute Event Rate: 5% vs 16.3%
p-value: p=<0.001
Right stellate ganglion block combined with dexmedetomidine attenuates electrical and structural remodeling in a rat model of AF-like atrial tachyarrhythmia, though the incremental benefit of adding dexmedetomidine requires further study.
To evaluate right stellate ganglion block (SGB) plus dexmedetomidine (Dex) in a rat model of atrial fibrillation-like (AF-like) atrial tachyarrhythmia. Methods: Male Sprague-Dawley rats were assigned to Sham, AF, AF+amiodarone, AF + SGB and AF + SGB+Dex groups. AF-like atrial tachyarrhythmia was induced by daily CaCl₂-acetylcholine injections for 7 days, and interventions were administered 1 h before modelling. ECG, echocardiography, electrophysiology, histology, ELISA, Western blot/qPCR, immunofluorescence and electron microscopy were performed. Results: Compared with the AF group, SGB + Dex reduced arrhythmia duration (5.0 ± 1.5 vs. 16.3 ± 2.5 s, p < 0.001) and ventricular rate (344.3 ± 19.9 vs. 398.1 ± 19.2 bpm, p = 0.004), preserved LVEF (83.3% ± 9.2% vs. 72.2% ± 6.7%, p = 0.032), attenuated left atrial enlargement and fibrosis, partially reversed effective refractory period shortening, reduced inducibility, decreased collagen I/III, TGF-β1 and TNF-α, and altered SK2 expression in the stellate ganglion. Direct SGB versus SGB + Dex comparisons were not statistically significant across most major endpoints. Conclusion: Right SGB + Dex was associated with attenuation of electrical and structural remodelling in this AF-like atrial tachyarrhythmia model. These findings support a protective SGB-based strategy but remain associative. Because no Dex-only group was included, the independent contribution of Dex and the incremental benefit of adding Dex to SGB require further investigation.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2026) studied Atrial fibrillation-like atrial tachyarrhythmia (n=30). Right stellate ganglion block (SGB) plus dexmedetomidine (Dex) vs. Atrial fibrillation model (AF) group was evaluated on Arrhythmia duration (seconds) (p=<0.001). Right stellate ganglion block combined with dexmedetomidine significantly reduced arrhythmia duration (5.0 vs 16.3 s, p < 0.001) and ventricular rate compared to the AF control group in rats.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: